SMAD3 and diabetes mellitus: The underlying mechanism is that the overactivated RAAS is inhibited, which reduce the transformation of fibroblasts into myofibroblasts, mediated by the activated TGF-β1/Smad3 pathway, thereby leading to reducing the collagen synthesis and improving the cardiac remodeling induced by diabetes.